The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Role of cholesterol and lipid organization in disease
Maxfield, F. R., & Tabas, I. (2005) · Nature · doi:10.1038/nature04399 · Cited by 1,293
Postic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
The glucose-regulated proteins: stress induction and clinical applications
Lee, A. S. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01908-9 · Cited by 1,032
Decoding cell death signals in liver inflammation
Brenner, C., Galluzzi, L., Kepp, O., & Kroemer, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.033 · Cited by 1,022
Orchestrating the unfolded protein response in health and disease
Kaufman, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216886 · Cited by 1,015
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Tripartite Management of Unfolded Proteins in the Endoplasmic Reticulum
Mori, K. (2000) · Cell · doi:10.1016/s0092-8674(00)80855-7 · Cited by 918
Pathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894
The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages
Feng, B., Yao, P. M., Li, Y., Devlin, C. M., Zhang, D., Harding, H. P., Sweeney, M., Rong, J. X., Kuriakose, G., Fisher, E. A., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb1035 · Cited by 885
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
Calkin, A. C., & Tontonoz, P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3312 · Cited by 779
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
Birkenfeld, A. L., & Shulman, G. I. (2014) · Hepatology · doi:10.1002/hep.26672 · Cited by 738
Translational control in the endoplasmic reticulum stress response
Ron, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216784 · Cited by 726
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c
Ferré, P., & Foufelle, F. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01275.x · Cited by 704
Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice
Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I., & Thurman, R. G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70354-9 · Cited by 701
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
MUSSO, G., GAMBINO, R., & CASSADER, M. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.08.001 · Cited by 681
Hepatic fibrosis: concept to treatment
Trautwein, C., Friedman, S. L., Schuppan, D., & Pinzani, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.039 · Cited by 677
Sterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
Cheung, O., Puri, P., Eicken, C., Contos, M. J., Mirshahi, F., Maher, J. W., Kellum, J. M., Min, H., Luketic, V. A., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22569 · Cited by 658
Min, H.-K., Kapoor, A., Fuchs, M., Mirshahi, F., Zhou, H., Maher, J., Kellum, J., Warnick, R., Contos, M. J., & Sanyal, A. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.004 · Cited by 652
Meyre, D., Delplanque, J., Chèvre, J.-C., Lecoeur, C., Lobbens, S., Gallina, S., Durand, E., Vatin, V., Degraeve, F., Proença, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.301 · Cited by 652
Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
Liu, Y.-L., Reeves, H. L., Burt, A. D., Tiniakos, D., McPherson, S., Leathart, J. B. S., Allison, M. E. D., Alexander, G. J., Piguet, A.-C., Anty, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5309 · Cited by 623
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
Kalaany, N. Y., & Mangelsdorf, D. J. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.033104.152158 · Cited by 615
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J. C., & García-Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 608
Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
Puri, P., Mirshahi, F., Cheung, O., Natarajan, R., Maher, J. W., Kellum, J. M., & Sanyal, A. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.039 · Cited by 597
The Role of Endoplasmic Reticulum in Hepatic Lipid Homeostasis and Stress Signaling
Fu, S., Watkins, S. M., & Hotamisligil, G. S. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.007 · Cited by 545
De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose
Sanders, F. W. B., & Griffin, J. L. (2016) · Biological Reviews · doi:10.1111/brv.12178 · Cited by 539
Wang, D., Wei, Y., & Pagliassotti, M. J. (2006) · Endocrinology · doi:10.1210/en.2005-0570 · Cited by 529
Jordan, S. D., Krüger, M., Willmes, D. M., Redemann, N., Wunderlich, F. T., Brönneke, H. S., Merkwirth, C., Kashkar, H., Olkkonen, V. M., Böttger, T., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2211 · Cited by 520
The Farnesoid X Receptor: A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism
Claudel, T., Staels, B., & Kuipers, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000178994.21828.a7 · Cited by 504
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Wree, A., McGeough, M. D., Peña, C. A., Schlattjan, M., Li, H., Inzaugarat, M. E., Messer, K., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1170-1 · Cited by 486
Adaptive immunity in obesity and insulin resistance
Sell, H., Habich, C., & Eckel, J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.114 · Cited by 486
Pathology of nonalcoholic fatty liver disease
Brunt, E. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.21 · Cited by 484
Wouters, K., van Gorp, P. J., Bieghs, V., Gijbels, M. J., Duimel, H., Lütjohann, D., Kerksiek, A., van Kruchten, R., Maeda, N., Staels, B., et al. (2008) · Hepatology · doi:10.1002/hep.22363 · Cited by 476
Pathology of Nonalcoholic Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2007) · American Journal of Clinical Pathology · doi:10.1309/rtpm1py6ygbl2g2r · Cited by 469
Miquilena-Colina, M. E., Lima-Cabello, E., Sánchez-Campos, S., García-Mediavilla, M. V., Fernández-Bermejo, M., Lozano-Rodríguez, T., Vargas-Castrillón, J., Buqué, X., Ochoa, B., Aspichueta, P., et al. (2011) · Gut · doi:10.1136/gut.2010.222844 · Cited by 451
FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
Potthoff, M. J., Boney-Montoya, J., Choi, M., He, T., Sunny, N. E., Satapati, S., Suino-Powell, K., Xu, H. E., Gerard, R. D., Finck, B. N., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.019 · Cited by 431
Regulation of adipocyte lipolysis
Frühbeck, G., Méndez-Giménez, L., Fernández-Formoso, J.-A., Fernández, S., & Rodríguez, A. (2014) · Nutrition Research Reviews · doi:10.1017/s095442241400002x · Cited by 429
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
Koo, S.-H. (2013) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2013.19.3.210 · Cited by 421
Liver X receptor in cholesterol metabolism
Zhao, C., & Dahlman-Wright, K. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0271 · Cited by 418
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
Musso, G., Gambino, R., & Cassader, M. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.11.002 · Cited by 409
Adipose tissue dysfunction contributes to obesity related metabolic diseases
Blüher, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.02.005 · Cited by 408
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Alkhouri, N., Dixon, L. J., & Feldstein, A. E. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.32 · Cited by 399
The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis
Lambert, G., Amar, M. J. A., Guo, G., Brewer, H. B., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209525200 · Cited by 392
Statin use and non-alcoholic steatohepatitis in at risk individuals
Dongiovanni, P., Petta, S., Mannisto, V., Mancina, R. M., Pipitone, R., Karja, V., Maggioni, M., Kakela, P., Wiklund, O., Mozzi, E., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.006 · Cited by 390
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
Nielsen, T. S., Jessen, N., Jørgensen, J. O. L., Møller, N., & Lund, S. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0277 · Cited by 380
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 376
Ota, T., Gayet, C., & Ginsberg, H. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32752 · Cited by 376
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
Caballero, F., Fernández, A., De Lacy, A. M., Fernández-Checa, J. C., Caballería, J., & García-Ruiz, C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.016 · Cited by 368
Hepatic insulin resistance directly promotes formation of cholesterol gallstones
Biddinger, S. B., Haas, J. T., Yu, B. B., Bezy, O., Jing, E., Zhang, W., Unterman, T. G., Carey, M. C., & Kahn, C. R. (2008) · Nature Medicine · doi:10.1038/nm1785 · Cited by 368
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355
Lu, K., Lee, M.-H., Hazard, S., Brooks-Wilson, A., Hidaka, H., Kojima, H., Ose, L., Stalenhoef, A. F. H., Mietinnen, T., Bjorkhem, I., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/321294 · Cited by 355
Sanyal, A. J., Friedman, S. L., McCullough, A. J., & Dimick‐Santos, L. (2015) · Hepatology · doi:10.1002/hep.27678 · Cited by 354
Panjwani, N., Mulvihill, E. E., Longuet, C., Yusta, B., Campbell, J. E., Brown, T. J., Streutker, C., Holland, D., Cao, X., Baggio, L. L., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1937 · Cited by 346
Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
Van Rooyen, D. M., Larter, C. Z., Haigh, W. G., Yeh, M. M., Ioannou, G., Kuver, R., Lee, S. P., Teoh, N. C., & Farrell, G. C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.040 · Cited by 345
Loomba, R., Sirlin, C. B., Ang, B., Bettencourt, R., Jain, R., Salotti, J., Soaft, L., Hooker, J., Kono, Y., Bhatt, A., et al. (2015) · Hepatology · doi:10.1002/hep.27647 · Cited by 344
Jovaisaite, V., Mouchiroud, L., & Auwerx, J. (2014) · Journal of Experimental Biology · doi:10.1242/jeb.090738 · Cited by 335
Anstee, Q. M., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.182 · Cited by 333
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih, M., & Jornayvaz, F. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.018 · Cited by 330
Tomita, K., Teratani, T., Suzuki, T., Shimizu, M., Sato, H., Narimatsu, K., Okada, Y., Kurihara, C., Irie, R., Yokoyama, H., et al. (2014) · Hepatology · doi:10.1002/hep.26604 · Cited by 315
Chiu, S., Sievenpiper, J. L., de Souza, R. J., Cozma, A. I., Mirrahimi, A., Carleton, A. J., Ha, V, Di Buono, M., Jenkins, A. L., Leiter, L. A., et al. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.8 · Cited by 314
Dietary fructose in nonalcoholic fatty liver disease
Vos, M. B., & Lavine, J. E. (2013) · Hepatology · doi:10.1002/hep.26299 · Cited by 314
Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism
Trauner, M., Claudel, T., Fickert, P., Moustafa, T., & Wagner, M. (2010) · Digestive Diseases · doi:10.1159/000282091 · Cited by 312
StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism
Soccio, R. E., & Breslow, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300003200 · Cited by 308
Chiang, J. Y. L., Kimmel, R., Weinberger, C., & Stroup, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10918 · Cited by 304
Role of ceramides in nonalcoholic fatty liver disease
Pagadala, M., Kasumov, T., McCullough, A. J., Zein, N. N., & Kirwan, J. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.04.005 · Cited by 303
The role of the StAR protein in steroidogenesis: challenges for the future
Stocco, D. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1640247 · Cited by 303
Savard, C., Tartaglione, E. V., Kuver, R., Haigh, G. W., Farrell, G. C., Subramanian, S., Chait, A., Yeh, M. M., Quinn, L. S., & Ioannou, G. N. (2013) · Hepatology · doi:10.1002/hep.25789 · Cited by 295
Trauner, M., Arrese, M., & Wagner, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.10.007 · Cited by 291
Self-citationHepatic mitochondrial glutathione: transport and role in disease and toxicity
Fernandez-Checa, J. C., & Kaplowitz, N. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.001 · Cited by 288
A concise review of non-alcoholic fatty liver disease
Than, N. N., & Newsome, P. N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.001 · Cited by 287
Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease
Tamura, S., & Shimomura, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524930 · Cited by 287
Miura, K., Yang, L., van Rooijen, N., Brenner, D. A., Ohnishi, H., & Seki, E. (2013) · Hepatology · doi:10.1002/hep.26081 · Cited by 282
Doege, H., Baillie, R. A., Ortegon, A. M., Tsang, B., Wu, Q., Punreddy, S., Hirsch, D., Watson, N., Gimeno, R. E., & Stahl, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.006 · Cited by 279
Selection of the appropriate method for the assessment of insulin resistance
Borai, A., Livingstone, C., Kaddam, I., & Ferns, G. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-158 · Cited by 268
Current efforts and trends in the treatment of NASH
Ratziu, V., Goodman, Z., & Sanyal, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.041 · Cited by 262
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Adorini, L., Pruzanski, M., & Shapiro, D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.012 · Cited by 259
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches
Schuppan, D., & Schattenberg, J. M. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12212 · Cited by 256
Chung, M., Ma, J., Patel, K., Berger, S., Lau, J., & Lichtenstein, A. H. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.086314 · Cited by 253
Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
Ioannou, G. N., Haigh, W. G., Thorning, D., & Savard, C. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m034876 · Cited by 253
Watari, H., Arakane, F., Moog-Lutz, C., Kallen, C. B., Tomasetto, C., Gerton, G. L., Rio, M.-C., Baker, M. E., & Strauss, J. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8462 · Cited by 247
Leroux, A., Ferrere, G., Godie, V., Cailleux, F., Renoud, M.-L., Gaudin, F., Naveau, S., Prévot, S., Makhzami, S., Perlemuter, G., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.028 · Cited by 246
Multilayered Genetic and Omics Dissection of Mitochondrial Activity in a Mouse Reference Population
Wu, Y., Williams, E. G., Dubuis, S., Mottis, A., Jovaisaite, V., Houten, S. M., Argmann, C. A., Faridi, P., Wolski, W., Kutalik, Z., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.039 · Cited by 244
Le, T.-A., Chen, J., Changchien, C., Peterson, M. R., Kono, Y., Patton, H., Cohen, B. L., Brenner, D., Sirlin, C., & Loomba, R. (2012) · Hepatology · doi:10.1002/hep.25731 · Cited by 243
Complex lipid trafficking in Niemann‐Pick disease type C
Vanier, M. T. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9794-4 · Cited by 242
Teratani, T., Tomita, K., Suzuki, T., Oshikawa, T., Yokoyama, H., Shimamura, K., Tominaga, S., Hiroi, S., Irie, R., Okada, Y., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.09.049 · Cited by 241
Li, L., Chen, L., Hu, L., Liu, Y., Sun, H.-Y., Tang, J., Hou, Y.-J., Chang, Y.-X., Tu, Q.-Q., Feng, G.-S., et al. (2011) · Hepatology · doi:10.1002/hep.24552 · Cited by 234
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Fon Tacer, K., & Rozman, D. (2011) · Journal of Lipids · doi:10.1155/2011/783976 · Cited by 231
Siddiqui, M. S., Fuchs, M., Idowu, M. O., Luketic, V. A., Boyett, S., Sargeant, C., Stravitz, R. T., Puri, P., Matherly, S., Sterling, R. K., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.008 · Cited by 231
Yilmaz, Y. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12046 · Cited by 218
Yasutake, K., Nakamuta, M., Shima, Y., Ohyama, A., Masuda, K., Haruta, N., Fujino, T., Aoyagi, Y., Fukuizumi, K., Yoshimoto, T., et al. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802588133 · Cited by 217
Cell biology of liver endothelial and Kupffer cells.
Smedsrød, B., De Bleser, P. J., Braet, F., Lovisetti, P., Vanderkerken, K., Wisse, E., & Geerts, A. (1994) · Gut · doi:10.1136/gut.35.11.1509 · Cited by 216
Altered Cholesterol Metabolism in Niemann-Pick Type C1 Mouse Brains Affects Mitochondrial Function
Yu, W., Gong, J.-S., Ko, M., Garver, W. S., Yanagisawa, K., & Michikawa, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412898200 · Cited by 207
Cable, E. E., Finn, P. D., Stebbins, J. W., Hou, J., Ito, B. R., van Poelje, P. D., Linemeyer, D. L., & Erion, M. D. (2009) · Hepatology · doi:10.1002/hep.22572 · Cited by 206
Newberry, E. P., Xie, Y., Kennedy, S. M., Luo, J., & Davidson, N. O. (2006) · Hepatology · doi:10.1002/hep.21369 · Cited by 204
Charman, M., Kennedy, B. E., Osborne, N., & Karten, B. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002345 · Cited by 198
Gan, L. T., Van Rooyen, D. M., Koina, M. E., McCuskey, R. S., Teoh, N. C., & Farrell, G. C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.024 · Cited by 198
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis
Hirsova, P., & Gores, G. J. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.005 · Cited by 197
ER stress response: Getting the UPR hand on misfolded proteins
Hampton, R. Y. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00583-2 · Cited by 192
Meijer, C., Wiezer, M. J., Diehl, A. M., Yang, S., Schouten, H. J., Meijer, S., Van Rooijen, N., Van Lambalgen, A. A., Dijkstra, C. D., & Van Leeuwen, P. A. M. (2000) · Liver · doi:10.1034/j.1600-0676.2000.020001066.x · Cited by 191
Pogribny, I. P., Starlard-Davenport, A., Tryndyak, V. P., Han, T., Ross, S. A., Rusyn, I., & Beland, F. A. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.113 · Cited by 185
Differential expression of microRNAs in mouse liver under aberrant energy metabolic status
Li, S., Chen, X., Zhang, H., Liang, X., Xiang, Y., Yu, C., Zen, K., Li, Y., & Zhang, C.-Y. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800509-jlr200 · Cited by 184
Current concepts in the pathogenesis of nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Arrese, M., Zamora‐Valdés, D., & Uribe, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01483.x · Cited by 184
Self-citationPredictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass
Boza, C., Riquelme, A., Ibañez, L., Duarte, I., Norero, E., Viviani, P., Soza, A., Fernandez, J. I., Raddatz, A., Guzman, S., et al. (2005) · Obesity Surgery · doi:10.1381/0960892055002347 · Cited by 183
Self-citationLipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Fisher, E., & Cohen, D. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1358519 · Cited by 179
Oxysterols and Their Cellular Effectors
Olkkonen, V. M., Béaslas, O., & Nissilä, E. (2012) · Biomolecules · doi:10.3390/biom2010076 · Cited by 178
Alpy, F., Stoeckel, M.-E., Dierich, A., Escola, J.-M., Wendling, C., Chenard, M.-P., Vanier, M. T., Gruenberg, J., Tomasetto, C., & Rio, M.-C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006279200 · Cited by 176
Lluis, J. M., Colell, A., García–Ruiz, C., Kaplowitz, N., & Fernández–Checa, J. C. (2003) · Gastroenterology · doi:10.1053/gast.2003.50089 · Cited by 173
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Eslami, L., Merat, S., Malekzadeh, R., Nasseri‐Moghaddam, S., & Aramin, H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008623.pub2 · Cited by 165
Pathophysiology of NASH: perspectives for a targeted treatment
Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990344 · Cited by 163
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
Zheng, S., Hoos, L., Cook, J., Tetzloff, G., Davis, H., van Heek, M., & Hwa, J. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.045 · Cited by 163
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
Deushi, M., Nomura, M., Kawakami, A., Haraguchi, M., Ito, M., Okazaki, M., Ishii, H., & Yoshida, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.023 · Cited by 163
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease
Pastori, D., Polimeni, L., Baratta, F., Pani, A., Del Ben, M., & Angelico, F. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.07.170 · Cited by 162
Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches
Lomonaco, R., Sunny, N. E., Bril, F., & Cusi, K. (2013) · Drugs · doi:10.1007/s40265-012-0004-0 · Cited by 158
Physiological and pathological implications of cholesterol
Cortés, V., Busso, D., Maiz, A., Arteaga, A., Nervi, F. O., & Rigotti, A. (2014) · Frontiers in bioscience · doi:10.2741/4216 · Cited by 157
Simonen, P. P., Kotronen, A., Hallikainen, M., Sevastianova, K., Makkonen, J., Hakkarainen, A., Lundbom, N. M. I., Miettinen, T. A., Gylling, H. K., & Yki‐Järvinen, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.037 · Cited by 157
Colell, A., García‐Ruiz, C., Lluis, J. M., Coll, O., Marí, M., & Fernández-Checa, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210943200 · Cited by 153
Coll, O., Colell, A., García‐Ruiz, C., Kaplowitz, N., & Fernández-Checa, J. C. (2003) · Hepatology · doi:10.1053/jhep.2003.50351 · Cited by 151
Kurek, K., Ziembicka, D., Wiesiołek‐Kurek, P., Łukaszuk, B., Chabowski, A., Górski, J., & Żendzian‐Piotrowska, M. (2013) · Liver International · doi:10.1111/liv.12331 · Cited by 150
Riquelme, A. J., Arrese, M. A., Soza, A., Morales, A., Baudrand, R. F., Pérez‐Ayuso, R. M., Gonzalez, R. G., Alvarez, M. G., Hernández, V., García‐Zattera, M. J., et al. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01823.x · Cited by 149
Self-citationSun, C., Huang, F., LIU, X., Xiao, X., Yang, M., Hu, G. M., Liu, H., & Liao, L. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2076 · Cited by 147
Kolditz, C.-I., & Langin, D. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833bed6a · Cited by 145
OSBP-related Protein 8 (ORP8) Suppresses ABCA1 Expression and Cholesterol Efflux from Macrophages
Yan, D., Mäyränpää, M. I., Wong, J., Perttilä, J., Lehto, M. J., Jauhiainen, M., Kovanen, P. T., Ehnholm, C., Brown, A. J., & Olkkonen, V. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705313200 · Cited by 142
Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
Boursier, J., & Diehl, A. M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004559 · Cited by 141
Nonalcoholic fatty liver disease and liver transplantation
Angulo, P. (2006) · Liver Transplantation · doi:10.1002/lt.20738 · Cited by 140
Meli, R., Mattace Raso, G., & Calignano, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00177 · Cited by 137
Takeshita, Y., Takamura, T., Honda, M., Kita, Y., Zen, Y., Kato, K., Misu, H., Ota, T., Nakamura, M., Yamada, K., et al. (2014) · Diabetologia · doi:10.1007/s00125-013-3149-9 · Cited by 137
Rooyen, D. M. V., Gan, L. T., Yeh, M. M., Haigh, W. G., Larter, C. Z., Ioannou, G. N., Teoh, N., & Farrell, G. C. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.024 · Cited by 132
FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
Carr, R. M., & Reid, A. E. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0500-2 · Cited by 132
Montero, J., Marí, M., Colell, A., Morales, A., Basáñez, G., García‐Ruiz, C., & Fernández-Checa, J. C. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.010 · Cited by 130
Abnormalities of Lipid Metabolism in Nonalcoholic Fatty Liver Disease
Cheung, O., & Sanyal, A. J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091979 · Cited by 127
Fibrosis in Nonalcoholic Fatty Liver Disease: Mechanisms and Clinical Implications
Angulo, P., Machado, M., & Diehl, A. (2015) · Seminars in liver disease (Print) · doi:10.1055/s-0035-1550065 · Cited by 123
Bieghs, V., Verheyen, F., van Gorp, P. J., Hendrikx, T., Wouters, K., Lütjohann, D., Gijbels, M. J., Febbraio, M., Binder, C. J., Hofker, M. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034378 · Cited by 122
Non-alcoholic fatty liver disease: a practical approach to treatment
Dyson, J. K., Anstee, Q. M., & McPherson, S. (2014) · Frontline Gastroenterology · doi:10.1136/flgastro-2013-100404 · Cited by 122
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippé, J., & Jornayvaz, F. R. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 121
Renin‐angiotensin system and fibrosis in non‐alcoholic fatty liver disease
Goh, G. B., Pagadala, M. R., Dasarathy, J., Ünalp–Arida, A., Sargent, R., Hawkins, C., Sourianarayanane, A., Khiyami, A., Yerian, L. M., Pai, R. K., et al. (2014) · Liver International · doi:10.1111/liv.12611 · Cited by 121
He, J., Lee, J. H., Febbraio, M., & Xie, W. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011128 · Cited by 120
Byrne, C. D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03732.x · Cited by 118
Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
Wenfeng, Z., Wu, Y., Di, M., Jianping, G., Wu, C., & Huang, C. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31247-5 · Cited by 118
Caveolae and intracellular trafficking of cholesterol
Fielding, C. J., & Fielding, P. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00140-5 · Cited by 116
Rai, R. M., Loffreda, S., Karp, C. L., Yang, S. Y., Lin, H., & Diehl, A. M. (1997) · Hepatology · doi:10.1002/hep.510250417 · Cited by 116
Fang, D., Wan, Y., Shen, W., Cao, J., Sun, Z.-X., Yu, H., Zhang, Q., Cheng, W., Chen, J., & Ning, B. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1694-7 · Cited by 116
Lade, A. G., Noon, L. A., & Friedman, S. L. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000042 · Cited by 112
Wouters, K., van Bilsen, M., van Gorp, P. J., Bieghs, V., Lütjohann, D., Kerksiek, A., Staels, B., Hofker, M. H., & Shiri-Sverdlov, R. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.046 · Cited by 109
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver
Cicione, C., Degirolamo, C., & Moschetta, A. (2012) · Hepatology · doi:10.1002/hep.25929 · Cited by 107
Gallstone disease in non‐alcoholic fatty liver: Prevalence and associated factors
Loria, P., Lonardo, A., Lombardini, S., Carulli, L., Verrone, A. M., Ganazzi, D., Rudilosso, A., D’Amico, R., Bertolotti, M., & Carulli, N. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03924.x · Cited by 106
Endoplasmic Reticulum Stress and the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
Gentile, C. L., Frye, M. A., & Pagliassotti, M. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3790 · Cited by 106
Carotti, S., Morini, S., Corradini, S. G., Burza, M. A., Molinaro, A., Carpino, G., Merli, M., Santis, A. D., Muda, A. O., Rossi, M., et al. (2008) · Liver Transplantation · doi:10.1002/lt.21436 · Cited by 105
Insights into the mechanisms of sterol transport between organelles
Mesmin, B., Antonny, B., & Drin, G. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1247-3 · Cited by 100
Ins and Outs Modulating Hepatic Triglyceride and Development of Nonalcoholic Fatty Liver Disease
Goldberg, I. J., & Ginsberg, H. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.040 · Cited by 99
Emerging and Disease-Specific Mechanisms of Hepatic Stellate Cell Activation
Wallace, M., Mann, D. A., & Friedman, S. L. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1550060 · Cited by 98
MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease
Jin, X., Ye, Y.-F., Chen, S.-H., Yu, C., Liu, J., & Li, Y.-M. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.08.008 · Cited by 98
Parlevliet, E. T., Wang, Y., Geerling, J. J., Schröder-Van der Elst, J. P., Picha, K., O'Neil, K., Stojanovic-Susulic, V., Ort, T., Havekes, L. M., Romijn, J. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049152 · Cited by 97
Tomita, K., Teratani, T., Suzuki, T., Shimizu, M., Sato, H., Narimatsu, K., Usui∥, S., Furuhashi, H., Kimura, A., Nishiyama, K., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.018 · Cited by 96
PNPLA3-Associated Steatohepatitis: Toward a Gene-Based Classification of Fatty Liver Disease
Krawczyk, M. J., Portincasa, P., & Lammert, F. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1358525 · Cited by 94
Zhao, L., Chen, Y., Tang, R., Chen, Y., Li, Q., Gong, J., Huang, A., Varghese, Z., Moorhead, J. F., & Ruan, X. Z. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06560.x · Cited by 92
McClain, C. J., Barve, S. S., & Deaciuc, I. V. (2007) · Hepatology · doi:10.1002/hep.21788 · Cited by 92
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Nozaki, Y., Fujita, K., Yoneda, M., Wada, K., Shinohara, Y., Takahashi, H., Kirikoshi, H., Inamori, M., Kubota, K., Saito, S., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.017 · Cited by 89
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
Insulin Regulation of Cholesterol 7α-Hydroxylase Expression in Human Hepatocytes
Li, T., Kong, X., Owsley, E., Ellis, E. C. S., Strom, S. C., & Chiang, J. Y. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605815200 · Cited by 87
Pizarro, M., Balasubramaniyan, N., Solís, N., Solar, A., Duarte, I., Miquel, J. F., Suchy, F. J., Trauner, M., Accatino, L., Ananthanarayanan, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037689 · Cited by 87
Self-citationCirculating microRNAs: Emerging Biomarkers of Liver Disease
Arrese, M. A., Eguchi, A., & Feldstein, A. E. (2015) · Seminars in Liver Disease · doi:10.1055/s-0034-1397348 · Cited by 86
Self-citationGori, M., Arciello, M., & Balsano, C. (2014) · BioMed Research International · doi:10.1155/2014/741465 · Cited by 84
The Inflammasome in Liver Injury and Non-Alcoholic Fatty Liver Disease
Mehal, W. Z. (2014) · Digestive Diseases · doi:10.1159/000360495 · Cited by 83
Mells, J. E., Fu, P. P., Kumar, P., Smith, T., Karpen, S. J., & Anania, F. A. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.11.002 · Cited by 83
Fibrosis in alcoholic and nonalcoholic steatohepatitis
Bataller, R. A., Rombouts, K., Altamirano, J., & Marra, F. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.010 · Cited by 83
SIRT2 negatively regulates insulin resistance in C2C12 skeletal muscle cells
Arora, A., & Dey, C. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.027 · Cited by 82
Beg, Z. H., Stonik, J. A., & Brewer, H. B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89648-x · Cited by 78
Endoplasmic reticulum stress impairs cholesterol efflux and synthesis in hepatic cells
Röhrl, C., Eigner, K., Winter, K. S., Korbelius, M., Obrowsky, S., Kratky, D., Kovacs, W. J., & Stangl, H. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m043299 · Cited by 75
Beg, Z. H., Stonik, J. A., & Brewer, H. B. (1987) · Metabolism · doi:10.1016/0026-0495(87)90101-6 · Cited by 73
Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis
Rinella, M. E., Siddiqui, S. M., Gardikiotes, K., Gottstein, J. H., Elias, M. S., & Green, R. M. (2011) · Hepatology · doi:10.1002/hep.24553 · Cited by 72
Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease
Machado, M. V., Gonçalves, S., Carepa, F., Coutinho, J., Costa, A., & Cortez‐Pinto, H. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02623.x · Cited by 71
Hager, L., Li, L., Pun, H., Liu, L., Hossain, M. A., Maguire, G. F., Naples, M., Baker, C., Magomedova, L., Tam, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340919 · Cited by 69
Cited by
Fenton, S. E., Ducatman, A., Boobis, A., DeWitt, J. C., Lau, C., Ng, C., Smith, J. S., & Roberts, S. M. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4890 · Cited by 2,445
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
Self-citationRecent insights into the pathogenesis of nonalcoholic fatty liver disease
Arab, J. P., Arrese, M., & Trauner, M. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043617 · Cited by 573
Self-citationMolecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Mota, M., Banini, B. A., Cazanave, S. C., & Sanyal, A. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.014 · Cited by 570
The Role of Cholesterol in the Pathogenesis of NASH
Ioannou, G. N. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.11.008 · Cited by 498
Metadata
- Authors
- Arguello, G., Balboa, E., Arrese, M., & Zanlungo, S.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 1852
- Issue
- 9
- Pages
- 1765-1778
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W356196484
- Cited by
- 306
- References
- 265
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.